1. Sun QF, Xu DZ, Pan SH, Ding JG, Xue ZQ, Miao CS, et al. Kimura disease: review of the literature. Intern Med J 2008;38:668-72.
2. Lee CC, Feng IJ, Chen YT, Weng SF, Chan LP, Lai CS, et al. Treatment algorithm for Kimura’s disease: a systematic review and meta-analysis of treatment modalities and prognostic predictors. Int J Surg 2022;100:106591.
3. Yuen HW, Goh YH, Low WK, Lim-Tan SK. Kimura’s disease: a diagnostic and therapeutic challenge. Singapore Med J 2005;46:179-83.
4. Hobeika CM, Mohammed TL, Johnson GL, Hansen K. Kimura’s disease: case report and review of the literature. J Thorac Imaging 2005;20:298-300.
6. Kim HT. Eosinophilic hyperplastic lymphogranuloma, comparison with Mikulicz’s disease. Chinese Med J 1937;23:699-70.
7. Kimura T. Unusual granulation combined with hyperplastic change of lymphatic tissue. Trans Soc Pathol Jpn 1948;37:179-80.
8. Hamrick HJ, Jennette JC, LaForce CF. Kimura’s disease: report of a pediatric case in the United States. J Allergy Clin Immunol 1984;73(5 Pt 1):561-6.
9. Yoganathan P, Meyer DR, Farber MG. Bilateral lacrimal gland involvement with Kimura disease in an African American male. Arch Ophthalmol 2004;122:917-9.
10. Jaber K. Kimura’s disease in an Arab female. Histopathology 1996;29:76-8.
11. Chen H, Thompson LD, Aguilera NS, Abbondanzo SL. Kimura disease: a clinicopathologic study of 21 cases. Am J Surg Pathol 2004;28:505-13.
12. Natov SN, Strom JA, Ucci A. Relapsing nephrotic syndrome in a patient with Kimura’s disease and IgA glomerulonephritis. Nephrol Dial Transplant 1998;13:2358-63.
15. Ohta N, Okazaki S, Fukase S, Akatsuka N, Aoyagi M, Yamakawa M. Serum concentrations of eosinophil cationic protein and eosinophils of patients with Kimura’s disease. Allergol Int 2007;56:45-9.
16. Kuo TT, Shih LY, Chan HL. Kimura’s disease: involvement of regional lymph nodes and distinction from angiolymphoid hyperplasia with eosinophilia. Am J Surg Pathol 1988;12:843-54.
17. Katagiri K, Itami S, Hatano Y, Yamaguchi T, Takayasu S. In vivo expression of IL-4, IL-5, IL-13 and IFN-gamma mRNAs in peripheral blood mononuclear cells and effect of cyclosporin A in a patient with Kimura’s disease. Br J Dermatol 1997;137:972-7.
20. Barber J, Dawes P. A rare cause of rash, eosinophilia and asthma in rheumatology. Rheumatology (Oxford) 2002;41:1329-30.
21. Khoo BP, Chan R. Kimura disease: 2 case reports and a literature review. Cutis 2002;70:57-61.
22. Mitsui M, Ogino S, Ochi K, Ohashi T. Three cases of eosinophilic lymphfolliculoid granuloma of the soft tissue originating from the parotid gland. Acta Otolaryngol Suppl 1996;522:130-2.
25. Terakado N, Sasaki A, Takebayashi T, Matsumura T, Kojou T. A case of Kimura’s disease of the hard palate. Int J Oral Maxillofac Surg 2002;31:222-4.
26. Okami K, Onuki J, Sakai A, Tanaka R, Hagino H, Takahashi M. Sleep apnea due to Kimura’s disease of the larynx: report of a case. ORL J Otorhinolaryngol Relat Spec 2003;65:242-4.
29. Goldenberg D, Gatot A, Barki Y, Leiberman A, Fliss DM. Computerized tomographic and ultrasonographic features of Kimura’s disease. J Laryngol Otol 1997;111:389-91.
31. Kung IT, Gibson JB, Bannatyne PM. Kimura’s disease: a clinico-pathological study of 21 cases and its distinction from angiolymphoid hyperplasia with eosinophilia. Pathology 1984;16:39-44.
34. Som PM, Biller HF. Kimura disease involving parotid gland and cervical nodes: CT and MR findings. J Comput Assist Tomogr 1992;16:320-2.
37. Wang TF, Liu SH, Kao CH, Chu SC, Kao RH, Li CC. Kimura’s disease with generalized lymphadenopathy demonstrated by positron emission tomography scan. Intern Med 2006;45:775-8.
38. Googe PB, Harris NL, Mihm MC Jr. Kimura’s disease and angiolymphoid hyperplasia with eosinophilia: two distinct histopathological entities. J Cutan Pathol 1987;14:263-71.
39. Don DM, Ishiyama A, Johnstone AK, Fu YS, Abemayor E. Angiolymphoid hyperplasia with eosinophilia and vascular tumors of the head and neck. Am J Otolaryngol 1996;17:240-5.
42. Ye P, Ma DQ, Yu GY, Gao Y, Peng X. Comparison of the efficacy of different treatment modalities for Kimura’s disease. Int J Oral Maxillofac Surg 2017;46:350-4.
43. Viswanatha B. Kimura’s disease in children: a 9 years prospective study. Int J Pediatr Otorhinolaryngol 2007;71:1521-5.
44. Birol A, Bozdogan O, Keleş H, Kazkayasi M, Bagci Y, Kara S, et al. Kimura’s disease in a Caucasian male treated with cyclosporine. Int J Dermatol 2005;44:1059-60.
45. Senel MF, Van Buren CT, Etheridge WB, Barcenas C, Jammal C, Kahan BD. Effects of cyclosporine, azathioprine and prednisone on Kimura’s disease and focal segmental glomerulosclerosis in renal transplant patients. Clin Nephrol 1996;45:18-21.
46. Kaneko K, Aoki M, Hattori S, Sato M, Kawana S. Successful treatment of Kimura’s disease with cyclosporine. J Am Acad Dermatol 1999;41(5 Pt 2):893-4.
48. Wang YS, Tay YK, Tan E, Poh WT. Treatment of Kimura’s disease with cyclosporine. J Dermatolog Treat 2005;16:242-4.
49. Miki H, Tsuboi H, Kaneko S, Takahashi H, Yokosawa M, Asashima H, et al. A case of refractory Kimura disease with a buccal bulky mass successfully treated with low-dose cyclosporine A: report and review of the literature. Allergol Int 2016;65:212-4.
52. Nonaka M, Sakitani E, Yoshihara T. Anti-IgE therapy to Kimura’s disease: a pilot study. Auris Nasus Larynx 2014;41:384-8.
54. Buchdunger E, Cioffi CL, Law N, Stover D, Ohno-Jones S, Druker BJ, et al. Abl protein-tyrosine kinase inhibitor STI571 inhibits in vitro signal transduction mediated by c-kit and platelet-derived growth factor receptors. J Pharmacol Exp Ther 2000;295:139-45.
55. Hareyama M, Oouchi A, Nagakura H, Asakura K, Saito A, Satoh M, et al. Radiotherapy for Kimura’s disease: the optimum dosage. Int J Radiat Oncol Biol Phys 1998;40:647-51.
56. Chang AR, Kim K, Kim HJ, Kim IH, Park CI, Jun YK. Outcomes of Kimura’s disease after radiotherapy or nonradiotherapeutic treatment modalities. Int J Radiat Oncol Biol Phys 2006;65:1233-9.
57. Ye P, Wei T, Yu GY, Wu LL, Peng X. Comparison of local recurrence rate of three treatment modalities for Kimura disease. J Craniofac Surg 2016;27:170-4.
59. Lin YY, Jung SM, Ko SF, Toh CH, Wong AM, Chen YR, et al. Kimura’s disease: clinical and imaging parameters for the prediction of disease recurrence. Clin Imaging 2012;36:272-8.
60. Tsukagoshi H, Nagashima M, Horie T, Oyama T, Yoshii A, Sato T, et al. Kimura’s disease associated with bronchial asthma presenting eosinophilia and hyperimmunoglobulinemia E which were attenuated by suplatast tosilate (IPD-1151T). Intern Med 1998;37:1064-7.
61. Ben-Chetrit E, Amir G, Shalit M. Cetirizine: an effective agent in Kimura’s disease. Arthritis Rheum 2005;53:117-8.
62. Boulanger E, Gachot B, Verkarre V, Valensi F, Brousse N, Hermine O. All-trans-retinoic acid in the treatment of Kimura’s disease. Am J Hematol 2002;71:66.